Related Experiment Videos
Degradation of cellular and viral Fos proteins
C Acquaviva1, P Ferrara, G Bossis
1Institut de Génétique Moléculaire de Montpellier, UMR5535/IFR24, 1919, Montpellier, France.
Abstract:
c-Fos proto-oncoprotein is a short-lived transcription factor with oncogenic potential. We have shown that it is massively degraded by the proteasome in vivo under various experimental conditions. Other proteolytic systems including lysosomes and calpains, might, however, also marginally operate on it. Although there is evidence that c-Fos can be ubiquitinylated in vitro, the unambiguous demonstration that ubiquitinylation is necessary for its addressing to the proteasome in vivo is still lacking. c-Jun, one of the main dimerization partners of c-Fos within the AP-1 transcription complex, is also an unstable protein. Its degradation is clearly proteasome- and ubiquitin-dependent in vivo. Interestingly, several lines of evidence indicate that the addressing of c-Fos and c-Jun to the proteasome is, at least in part, governed by different mechanisms. c-Fos has been transduced by two murine osteosarcomatogenic retroviruses under mutated forms which are more stable and more oncogenic. The stabilization is not simply accounted for by simple deletion of c-Fos main destabilizer but, rather, by a complex balance between opposing destabilizing and stabilizing mutations. Though mutations in viral Fos proteins confer full resistance to proteasomal degradation, stabilization is limited because mutations also entail sensitivity to an unidentified proteolytic system. This observation is consistent with the idea that Fos-expressing viruses have evolved to ensure control protein levels to avoid high protein accumulation-linked apoptosis. In conclusion, the unveiling of the complex mechanism network responsible for the degradation of AP-1 family members is still at its beginning and a number of issues regarding the regulation of this process and the addressing to the proteasome are still unresolved.
Insights
The proteasome heavily degrades the oncogenic c-Fos protein, but its ubiquitinylation necessity for proteasomal targeting in vivo remains unclear. c-Fos and c-Jun degradation pathways differ, with viral Fos mutations impacting stability and oncogenicity.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- c-Fos proto-oncoprotein is a short-lived transcription factor with oncogenic potential.
- Its degradation is primarily mediated by the proteasome, though other systems may play minor roles.
- Ubiquitinylation's necessity for c-Fos proteasomal targeting in vivo is not definitively established.
Purpose of the Study:
- To investigate the degradation mechanisms of c-Fos and its dimerization partner c-Jun.
- To explore the role of ubiquitinylation in c-Fos proteasomal degradation.
- To analyze the stability and oncogenic potential of mutated viral Fos proteins.
Main Methods:
- Proteasome activity assays
- Ubiquitinylation studies in vitro and in vivo
- Analysis of mutated viral Fos proteins expressed in murine osteosarcoma models
Main Results:
- c-Fos is extensively degraded by the proteasome in vivo.
- c-Jun degradation is clearly proteasome- and ubiquitin-dependent.
- Mutated viral Fos proteins exhibit altered stability and oncogenicity, with resistance to proteasomal degradation but sensitivity to other proteolytic systems.
Conclusions:
- The degradation of AP-1 family members involves complex regulatory networks.
- Distinct mechanisms govern the proteasomal targeting of c-Fos and c-Jun.
- Viral Fos mutations modulate protein stability and oncogenicity, suggesting evolutionary control to prevent apoptosis.